Value Investments for Your Stock Portfolio

Tag: DeepValue

A confident insurance executive in a tailored suit stands on a bridge connecting a suburban American neighborhood to a modern global financial skyline. One side features homes, mortgages, and family life; the other displays specialty insurance markets.

🏠 Radian Group Inc. (NYSE: RDN): New C-Suite Blood, The $1.7 Billion Global Pivot, and a Comical 6x Valuation

A new CEO. A $5.8 million insider purchase. A $1.7 billion transformational acquisition. And a stock trading below book value at just 6.6x forward earnings. Is Wall Street overlooking one of the most compelling value opportunities in financials?

Read entire article

Tags: book value investing, buy or sell RDN, CEO purchase, cheap stocks, contrarian investing, DeepValue, dividend stocks, DividendStock, featured-value, financial sector, financial stocks, FUNanc1al, GARP, Howard Marks style investing, hub-insiders, hub-value, Inigo acquisition, InigoAcquisition, insider buying, InsiderBuying, MichaelWeinbach, mortgage insurance, MortgageInsurance, NYSE RDN, Radian Group, RadianGroup, RDN, risks buying RDN, shareholder returns, ShareRepurchaseProgram, specialty insurance, SpecialtyInsurance, stock analysis, stock market, value investing, ValueInvesting, Warren Buffett investing, why buy RDN
Stethoscope wrapped around a red clearance tag marked 'Centene: 50% Off!' symbolizing the stock’s sharp drop after insider purchases at double the price.

Centene Corp (CNC): Fire Sale or Just Burnt Crust?

Centene stock has cratered to $29 after guidance withdrawal and rising Medicaid costs. But insiders bought at $60, institutions still believe, and the valuation? Downright ridiculous. Here's why this might be healthcare's most misunderstood fire-sale. 📉💊

Read entire article

Tags: Centene, CEO insider buying, CFO Insider Buying, CNC, DeepValue, Director Insider Buying, Funanc1al Insider Series, Funanc1alInsiderSeries, HealthcareStocks, InsiderBuying, StocksToWatch, ValueInvesting